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Abstract The analysis of Δ9-tetrahydrocannabinol (THC)
and its metabolites 11-hydroxy-Δ9-tetrahydrocannabinol
(11-OH-THC), and 11-nor-9-carboxy-Δ9-tetrahydrocannabi-
nol (THC-COOH) from blood serum is a routine task in fo-
rensic toxicology laboratories. For examination of consump-
tion habits, the concentration of the phase I metabolite THC-
COOH is used. Recommendations for interpretation of anal-
ysis values in medical-psychological assessments (regranting
of driver’s licenses, Germany) include threshold values for the
free, unconjugated THC-COOH. Using a fully automated
two-step liquid-liquid extraction, THC, 11-OH-THC, and
free, unconjugated THC-COOH were extracted from blood
serum, silylated with N-methyl-N-(trimethylsilyl)
trifluoroacetamide (MSTFA), and analyzed by GC/MS. The
automation was carried out by an x-y-z sample robot equipped
with modules for shaking, centrifugation, and solvent evapo-
ration. This method was based on a previously developed
manual sample preparation method. Validation guidelines of
the Society of Toxicological and Forensic Chemistry
(GTFCh) were fulfilled for both methods, at which the focus
of this article is the automated one. Limits of detection and
quantification for THC were 0.3 and 0.6 μg/L, for 11-OH-
THC were 0.1 and 0.8 μg/L, and for THC-COOH were 0.3
and 1.1 μg/L, when extracting only 0.5 mL of blood serum.
Therefore, the required limit of quantification for THC of
1 μg/L in driving under the influence of cannabis cases in
Germany (and other countries) can be reached and the method
can be employed in that context. Real and external control
samples were analyzed, and a round robin test was passed
successfully. To date, the method is employed in the Institute
of Legal Medicine in Giessen, Germany, in daily routine.
Automation helps in avoiding errors during sample prepara-
tion and reduces the workload of the laboratory personnel.
Due to its flexibility, the analysis system can be employed
for other liquid-liquid extractions as well. To the best of our
knowledge, this is the first publication on a comprehensively
automated classical liquid-liquid extraction workflow in the
field of forensic toxicological analysis.
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Introduction
In the last decades, cannabis was, besides alcohol and tobacco,
the most commonly used and also the most controversial
discussed (illicit) drug in Germany. Also, driving under the
influence of cannabis is becoming a more and more serious
issue. Driving license regulations (German law: § 14 FeV
Annex 4 no. 9.2) imply that the aptitude for driving a vehicle
is not given if regular cannabis consumption can be proven. In
such cases, the driving license can be denuded.
In forensic laboratories, evaluation of cannabis consump-
tion is done by urine, blood, hair, or saliva analysis. In hair and
urine, cannabinoids can be detected for a longer period of time
than in blood. Therefore, in Germany, these matrices are used
as part of an abstinence control in medical-psychological as-
sessments [1] to re-obtain the driver’s license. By determining
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Δ9-tetrahydrocannabinol (THC) and its metabolites in blood
(serum), laboratories determine the current state of
intoxication.
Δ9-Tetrahydrocannabinol is the main psychotropic com-
pound in cannabis which is metabolized in the body to 11-
hydroxy-Δ9-tetrahydrocannabinol (11-OH-THC), 11-nor-9-
carboxy-Δ9-tetrahydrocannabinol (THC-COOH), and 11-
nor-9-carboxy-Δ9-tetrahydrocannabinol glucuronide (THC-
COOgluc). In the first phase of metabolism in which oxida-
tion, reduction, and/or hydrolysis take place, THC is convert-
ed to the still pharmacologically active hydroxy metabolite
11-OH-THC. Afterwards, 11-OH-THC is oxidized in the liver
to the psychotropically inactive metabolite THC-COOH. This
is followed by the enzymatically catalyzed conjugation with
glucuronic acid to form the phase II metabolite THC-
COOgluc [2]. After 30–60 min, the concentration of the glu-
curonide exceeds that of the free carboxylic acid [3].
Glucuronidation makes the molecule more hydrophilic; thus,
the excretion via urine is improved and THC-COOgluc con-
stitutes the main metabolite in urine.
Up to a limit of 1 μg/LTHC in serum, it is considered that
the driving ability is not impaired (German law: § 24 a (2)
StVG). Moreover, there are limits for the slowly degrading
(half-life 6 days), inactive phase I metabolite THC-COOH
[4]. This analyte serves to evaluate the consumption behavior
of a driver. It must be ensured that only the free THC-COOH
(free carboxylic acid) concentration is determined and this is
not erroneously increased by coextraction and/or cleavage of
the conjugated phase II metabolite THC-COOgluc [5].
Originally, gas chromatographic separation coupled to
mass spectrometric detection with electron impact ionization
using the single ion monitoring mode (GC/EI-SIM-MS) was
employed to quantify cannabinoids in serum, plasma, or
whole blood [6–10]. Moreover, GC/MS with positive chemi-
cal ionization has been employed [11]. In order to gain selec-
tivity, GC/MS/MS methods have been developed, using elec-
tron impact [12] or negative chemical ionization [13]. Two-
dimensional GC/MS has been used as an alternative to im-
prove selectivity [14, 15]. Analyte derivatization is predomi-
nantly carried out with silylation reagents [9, 11, 12, 14, 15]
and sometimes with fluorinated compounds [6, 13] or meth-
ylation reagents [7, 8, 10]. In recent years, more and more
liquid chromatography tandem mass spectrometry (LC/MS/
MS) methods were described in the literature [16–23]. For
sample preparation, both solid-phase extraction (SPE) [7–12,
14–16, 19–21] and liquid-liquid extraction (LLE) techniques
[6, 13, 17, 18, 22] have been applied. In routine forensic anal-
ysis, oftentimes, liquid-liquid extraction with n-hexane/ethyl
acetate (9/1, v/v) is employed [6, 18, 22]. Under certain con-
ditions, THC-COOglucmay be coextracted and partly cleaved
during the derivatization step forming the THC-COOH deriv-
ative and thus leading to erroneously elevated THC-COOH
analysis values [20, 24].
Manual sample preparation normally comprises numerous
steps representing a significant workload for laboratory staff
with exposure to potentially toxic solvents and reagents, and it
means that errors are more likely to occur. Therefore, com-
plete automation of the analysis is preferable. Fully automated
and partly automated sample preparation, mainly for SPE, is
applied in some forensic laboratories. Benchtop systems using
standard SPE cartridges mimic the manual SPE workflow [9,
10]. Complete automation of sample preparation and analysis
is possible with online SPE systems where the SPE cartridge
is integrated into an LC flow path and the cartridge is auto-
matically exchangeable [19, 25] or not [16, 20]. Complete
automation of SPE, evaporation, derivatization, and injection
into a chromatographic system are possible as well [26].
Automation of liquid-liquid extraction is more difficult. It
can be realized in the form of, e.g. , single-drop
microextraction [27] or in 96-well format micro-tubes [28].
The aim of this study was the development of a compre-
hensively automated analysis method for the determination of
THC, THC-OH, and free THC-COOH in blood serum basing
on a previously developed manual method.
Materials and methods
Solvents, reagents, and standards
All analytes and deuterated analogs were certified standards.
(−)-Δ9-THC (1 g/L in methanol), (−)-Δ9-THC-d3, (±)-11-
hydroxy-Δ9-THC, (±)-11-hydroxy-Δ9-THC-d3, (±)-11-nor-
9-carboxy-Δ9-THC, (±)-11-nor-9-carboxy-Δ9-THC-d3, (+)-
11-nor-9-carboxy-Δ9-THC-glucuronide, and (±)-11-nor-9-
carboxy-Δ9-THC-d3-glucuronide (each 0.1 g/L in methanol)
were purchased from Cerilliant (Round Rock, USA). Blood
serum samples were taken from real forensic cases of the
Institute of Legal Medicine (Giessen, Germany). Internal
quality control (QC) samples consisted of drug-negative se-
rum given by voluntary donors from the institute spiked with
THC, 11-OH-THC, and THC-COOH. Two QCs were pre-
pared, the first one containing 1 μg/L THC and 11-THC-OH
and 10 μg/L THC-COOH and the second one containing
30 μg/L THC and 11-THC-OH, and 300 μg/L THC-COOH.
External quality control samples were certified reference ma-
terials (ACQ Science GmbH, Rottenburg-Hailfingen,
Germany). An internal standard solution was prepared at
5 μg/L THC-d3 and 11-OH-THC-d3 as well as 50 μg/L
THC-COOH-d3 in methanol. Calibration solutions were pre-
pared either by diluting the certified standards in methanol or
by spiking drug-negative serum.
All solvents were of analytical grade and purchased from
VWR (Darmstadt, Germany). For liquid-liquid extraction, a
mixture of n-hexane and ethyl acetate (9/1, v/v) was prepared.
N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) for
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silylation was from Macherey-Nagel (Dueren, Germany).
Derivatization was carried out either with pure MSTFA in
the manual workflow or with a mixture of MSTFA/ethyl ace-
tate (3/2, v/v) in the automated workflow.
Instrumentation—manual liquid-liquid extraction
workflow
For manual extraction, a Vortex-Genie 2 (Scientific
Industries, New York, USA) was employed. The extrac-
tion tubes were put into an EBA 200 centrifuge (Hettich,
Tuttlingen, Germany) for phase separation. After with-
drawal of the organic phase, it was evaporated in a
heating block (Barkey, Leopoldshöhe, Germany) with
ten nitrogen-streamed vial positions (Linde, Pullach,
Germany). Derivatization was carried out in a laboratory
oven (Memmert, Schwabach, Germany).
The extracts were analyzed with an 6890 GC/5973N
MSD (Agilent Technologies, Waldbronn, Germany). A 7683
autosampler was applied for injection into a hot split/splitless
inlet (Agilent Technologies). Analytes were separated on an
Optima 5 HT (30 m×0.25 mm, 0.25 μm film thickness,
Macherey-Nagel) column.
Instrumentation—automated liquid-liquid extraction
workflow
Comprehensive automation of sample preparation was based
on a MultiPurpose Sampler MPS (GERSTEL, Muelheim,
Germany; see Fig. 1) which is a flexible platform with numer-
ous available modules. It carried two syringes, a 1 mL for
sample preparation steps and a 10 μL for sample injection into
a 7890A GC/5975C MSD (Agilent Technologies) equipped
with a DB-5-MS (30 m×0.25 mm, 0.25 μm film thickness,
Agilent Technologies) column. TheMPSwas equipped with a
centrifuge (CF 200), a module for evaporation of solvents
under controlled vacuum and temperature (Multi Position
Evaporation Station, mVAP), a quickMix for sample extraction,
and a Solvent Filling Station (SFS 2, all GERSTEL) for sol-
vent supply. All sample preparation steps were performed in
septum-sealed vials with magnetic screw caps enabling trans-
port by the MPS. The system was controlled via Maestro
software (version 1.4.33.3, GERSTEL) which was integrated
into the ChemStation chromatography data system (version
E.02.02 SP1, Agilent Technologies). With this software con-
figuration, all sample preparation steps could be combined
freely and were included into the GC/MS analysis method.
Analysis methods—manual liquid-liquid extraction
workflow
One milliliter of blood serum was mixed with 50 μL of the
deuterated internal standard solution. Liquid-liquid extraction
was carried out with 5 mL n-hexane/ethyl acetate (9/1, v/v) for
1 min on a vor tex shaker. Af ter cent r i fugat ion
(RCF=2500×g), the organic phase was withdrawn; the re-
maining aqueous sample was acidified with 100 μL of 1 M
HCl (resulting pH 4–5), extracted, and centrifuged again to
obtain a second extract. The combined organic phases were
evaporated to dryness under nitrogen at 48 °C. For derivatiza-
tion, the dry sample was silylated with 50 μL MSTFA in an
oven at 80 °C for 30 min. Finally, 2 μL of the sample was
injected into the split/splitless inlet of the GC/MS at 280 °C.
Separation was achieved with a constant helium flow of
Fig. 1 GC/MS with MPS Dual
Head at the Institute of Legal
Medicine, Giessen, Germany.
Modules from left to right:
quickMix (for LLE), wash station,
tray 1 (vials for extracts), solvent
reservoir, mVAP (for extract
evaporation), Solvent Filling
Station (solvent supply), cooled
tray 2 (vials for serum samples),
and centrifuge (for phase
separation)
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1.3 mL/min and the following temperature program: 70 °C for
2 min, rate 20 °C/min to 250 °C for 4 min, rate 20 °C/min to
300 °C for 17 min. Mass spectrometric detection was done in
single ion monitoring (SIM) mode (see Table 1).
Analysis methods—automated liquid-liquid extraction
workflow
For automation, 0.5 mL of blood serum was manually
mixed with 25 μL of the deuterated internal standard so-
lution in a 4-mL vial. All further steps were carried out
fully automated by the MPS. The sample was extracted
with 1.5 mL n-hexane/ethyl acetate (9/1, v/v) for 3 min in
the quickMix and centrifuged for phase separation at
RCF= 2000×g for 7 min. The supernatant was taken into
another vial and evaporated to dryness under controlled
vacuum (1 min at 70 kPa, 3.5 min at 4 kPa) and temper-
ature (65 °C) and shaking (3.1 Hz) in the evaporation
station while the residue was acidified with 50 μL of
1 M HCl (resulting pH 4–5). After acidic extraction, again
with 1.5 mL n-hexane/ethyl acetate (9/1, v/v), the organic
phase was separated, transferred to the same extract vial,
and evaporated again until dryness was reached. A mix-
ture of 50 μL MSTFA/ethyl acetate (3/2, v/v) was added
to the dry residue, the vial was shortly shaken, and 2 μL
was injected into the hot split/splitless inlet (derivatization
at 280 °C) of the GC/MS. For practical reasons, the tem-
perature program was changed compared to the manual
method, since there was a second GC column for a dif-
ferent application installed in the same GC oven which
could not withstand temperatures higher than 260 °C.
Separation was performed with a constant helium flow
of 1.6 mL/min and the following temperature program:
70 °C for 2 min, rate 20 °C/min to 240 °C for 5 min, rate
20 °C/min to 250 °C for 6 min, rate 20 °C/min to 260 °C
for 5 min. Mass spectrometric detection was done in sin-
gle ion monitoring (SIM) mode (Table 1).
For calibration, both methanolic solutions and spiked se-
rum samples were employed. Methanolic calibration solutions
and the methanolic control samples were handled analogously
to the extracts. Calibration with solvent standards is often used
in forensic toxicology and is accepted by the Society of
Toxicological and Forensic Chemistry (GTFCh) if equiva-
lence with matrix calibration can be proven. The manual and
automated analysis methods were validated according to
GTFCh guidelines with the help of the software Valistat (ver-
sion 1.0) from Arvecon (Walldorf, Germany).
Analysis sequences comprised 20 real cases and four con-
trol samples (negative, low concentration, high concentration,
and external). According to GTFCh recommendations, a
blank injection of pure derivatization reagent was done before
every real sample.
Results and discussion
Method development
A dual-stage liquid-liquid extraction method for the determi-
nation of THC, 11-OH-THC, and free THC-COOH in blood
serum was developed. Considering the different pKa values of
the analytes, the first extraction was carried out at the native
pH of the blood serum (around pH 7). At this pH, mainly THC
and 11-OH-THC which are non-charged were extracted into
Table 1 Target and qualifier ions for analytes and deuterated internal
standards
Target (m/z) Qualifier 1 (m/z) Qualifier 2 (m/z)
THC 386 371 303
THC-d3 389 374 306
11-OH-THC 371 474 459
11-OH-THC-d3 374 477 462
THC-COOH 371 473 488
THC-COOH-d3 374 476 491
Table 2 Comparison of THC-
COOH/THC-COOH-d3 ratios for
blank serum spiked at 50 μg/L
with THC-COOH and THC-
COOH-d3 only and blank serum
additionally spiked at 50 μg/L
with THC-COOgluc. Analysis
results for THC-COOH are not
biased by THC-COOgluc
addition
Blank serum spiked with THC-COOH
and THC-COOH-d3
Blank serum additionally spiked with
THC-COOgluc
Difference
of ratios
Response
THC-COOH
Response
THC-COOH-d3
Ratio Response
THC-COOH
Response
THC-COOH-d3
Ratio
7348 6907 1.064 7395 6564 1.127 +0.063
7896 6884 1.147 8856 7833 1.131 −0.016
6854 6320 1.085 7606 6683 1.138 +0.054
7967 7176 1.110 6503 5468 1.189 +0.079
7409 6179 1.199 7935 7192 1.103 −0.096
Average 1.121 1.138 +0.017
4382 K. Purschke et al.
the organic phase. In the second extraction step, after acidifi-
cation of the residual sample to pH 4–5, free THC-COOHwas
extracted and separated from THC-COOgluc. At this pH,
THC-COOgluc (pKa ∼3.2 [29]) predominantly (about 90 %)
is present deprotonated (anionic) and thus cannot pass into the
organic phase. Free THC-COOH (pKa ∼4.2 [29]), however, is
protonated and non-charged (about 50 %) and can be extract-
ed into the organic phase. Maintaining the pH between 4 and 5
is crucial for the second extraction step. Major deviations can
lead to glucuronide cleavage [3] or coextraction of THC-
COOgluc which forms silylated THC-COOH during the de-
rivatization step. Eventually, both effects result in erroneously
elevated THC-COOH analysis values [20, 24].
For confirming that the developed analysis method
does not result in elevated THC-COOH values, the fol-
lowing experiment was conducted: 12 samples of blank
blood serum were spiked with equal amounts of THC-
COOH and the internal standard THC-COOH-d3. Six of
these samples were additionally spiked with THC-
COOgluc. The peak area ratio THC-COOH/THC-
COOH-d3 was calculated for all analyses. On average,
the samples additionally spiked with THC-COOgluc
showed a 1.5 % higher ratio proving that only negligible
amounts of THC-COOH were formed from THC-
COOgluc by the sample preparation steps (see Table 2).
In that respect, recommendations for interpretation of
analysis values in medical-psychological assessments re-
quiring the analysis of free THC-COOH only without in-
terferences by THC-COOgluc were fulfilled.
The developed two-step liquid-liquid extraction was suc-
cessfully and completely automated using a MultiPurpose
Sampler equipped with different modules (e.g., shaker, centri-
fuge, evaporator). Some analysis parameters were improved
or needed to be adapted for automation.
The sample volume could be reduced from 1 to 0.5 mL
serum. Also, the volume of the extraction solvent for each
extraction step was reduced from 5 to 1.5 mL n-hexane/
ethyl acetate (9/1, v/v). This enabled the use of 4-mL vials
for extraction, extending the sample capacity to 50 sam-
ples per sequence.
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(a) Derivatization in an oven at 80 °C for 30 min
(b) Inlet derivatization at 280 °C
THC
11-OH-THC
THC-COOHFig. 2 Chromatograms of serum
samples spiked with 4 μg/L THC
and THC-OH and 40 μg/L THC-
COOH after extraction and
derivatization with MSTFA in an
oven for 30 min at 80 °C (a) and
derivatization with MSTFA/ethyl
acetate (3/2, v/v) in the GC inlet at
280 °C (b)
Table 3 Excerpt of validation
data of the automated analysis
method according to GTFCh
guidelines
Analyte Concentration
[μg/L]
Repeatability:
RSDr [%]
Time-different
intermediate
precision: RSD(T)
[%]
Accuracy:
bias [%]
Extraction
efficiency
[%]
THC 1 7.8 6.1 2.1 109
30 2.1 8.5 0.7 103
11-OH-THC 1 8.3 8.1 4.1 120
30 1.8 8.7 −0.3 103
THC-COOH 10 2.4 6.3 3.0 121
300 0.9 12 0.9 104
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Centrifugation time and needle penetration depth for the
extract withdrawal step needed to be optimized carefully since
it is crucial to prevent contamination of the final extract by
residual serum. Also, optimal evaporation parameters had to
be found out ensuring on the one hand that the extract is
completely evaporated before derivatization and on the other
hand that the analytes are not exposed to heat in the mVAP
longer than necessary.
Analyte derivatization can be done during injection into the
hot split/splitless inlet with a mixture of MSTFA/ethyl acetate
(3/2, v/v) instead of pure MSTFA. In comparison to the 30-
min derivatization step in an oven, this saves time and in-
creases throughput while analytical performance is main-
tained. Chromatograms of the inlet derivatization showed less
and smaller background peaks than chromatograms received
with 30 min derivatization in an oven (see Fig. 2). The reduc-
tion of MSTFA volume percentage enhances the lifetime of
the analytical column and the autosampler syringe according
to former experiences with silylation reagents in our
laboratory.
Method validation
Requirements of the validation according to GTFCh guide-
lines [30] have been met at each point for both the manual
and automated methods. Only validation data for the automat-
ed method are discussed here.
Selectivity and specificity were checked by analyzing
six different serum samples spiked with opiates and ben-
zodiazepines as they could be present in real samples as
well. No interferences from the spiked drugs or the matrix
were recorded at the retention time of analytes and inter-
nal standards of interest.
Linearity of calibration was proven up to 35 μg/L for
THC and 11-OH-THC and up to 350 μg/L for THC-
COOH respectively. A calibration with standards in
methanol was equivalent to a matrix calibration and
therefore was employed for analyzing real samples.
Precision, accuracy, and extraction efficiency data can
be found in Table 3. All precision and accuracy values
were below the acceptable value of 15 %. The average
extraction efficiency was 110 % ranging from 103 to
121 %. Limits of quantification (LOQ) and detection
(LOD) for the respective compounds are listed in
Table 4. Most importantly, the limit of quantification
for THC was far below 1 μg/L, being an important limit
in driving under the influence of cannabis cases in
Germany and other countries. No carry-over was detect-
ed for any compound when analyzing a blank serum
sample after a serum sample spiked at the highest cali-
bration level (35 μg/L for THC and 11-OH-THC and
350 μg/L for THC-COOH). Freeze/thaw stability was
confirmed by three freezing and thawing cycles with
spiked QC samples of low (1.5 μg/L for THC and 11-
OH-THC and 15 μg/L for THC-COOH) and high
(12.5 μg/L for THC and 11-OH-THC and 125 μg/L for
THC-COOH) concentrations.
Furthermore, stability of the samples on the autosampler
tray during an analysis sequence was evaluated. For this, a
serum pool was spiked with 30 μg/LTHC and 11-OH-THC
and 300 μg/L THC-COOH and THC-COOgluc. Aliquots
of 0.5 mL were put into autosampler vials. The first series
Table 4 Limits of detection (LOD) and limits of quantification (LOQ)
for the automated method
THC [μg/L] 11-OH-THC [μg/L] THC-COOH [μg/L]
LOD 0.3 0.1 0.3
LOQ 0.6 0.8 1.1
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Fig. 3 Analysis values for a sequence of 28 blank serum samples spiked
with 30 μg/L THC and 11-OH-THC and 300 μg/L THC-COOH and
300 μg/L THC-COOgluc stored on a cooled tray at 4 °C. No increase
of the THC-COOH value by cleavage of THC-COOgluc can be observed
during the sequence run time of more than one day. Note that data points
for 11-OH-THC analysis values are overlapped by data points for THC
analysis values since these analytes were spiked at the same concentration
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of samples was processed immediately; the second series
was stored overnight on the autosampler tray at room tem-
perature. Average analysis values for THC and 11-OH-
THC were concordant. For THC-COOH, an increase of
around 10 % after storage could be observed which can
be explained by THC-COOgluc degradation and the for-
mation of THC-COOH. When storing the serum samples at
4 °C on a cooled tray and running a sequence of 28 sam-
ples (runtime more than 1 day), neither an increase nor a
decrease of analysis values could be observed for all
analytes (see Fig. 3). Cooling of samples is essential for
running analysis sequences over a long period of time.
LOQs of the developed automated method lie well
within published LOQs for GC/MS(/MS) [6, 8, 9, 11,
13] and LC/MS/MS [16–18, 20, 21] methods. In the lit-
erature, these were between 0.5 and 1 μg/L for THC and
11-OH-THC and between 0.8 and 4.3 μg/L for THC-
COOH. A sophisticated 2D-GC/MS method yielded
LOQs of 0.125 μg/L for THC and THC-COOH and
0.25 μg/L for 11-OH-THC respectively [14]. Extraction
efficiencies and recoveries mentioned in the literature
were mainly lower than in the present study which might
be caused by differences in the way of sample spiking. As
in our app l i ca t ion—excep t fo r THC-COOH at
300 μg/L—relative standard deviations (precision) in the
literature were below 10 %. A round robin test has been
passed successfully with the automated method and
analysis values for external control samples laid inside
the acceptable concentration ranges (Table 5).
Comparison of manual and automated methods
In order to check the newly validated methods (manual and
automated), 20 real samples from the Institute of Legal
Medicine in Giessen and various external controls were ana-
lyzed and compared.
Considering the fact that comparative analyses of real
samples were conducted on different instruments, the
concentration values fit quite well especially for the most
important analytes THC and THC-COOH (see Fig. 4a,
c). For 11-OH-THC, the deviation of analysis values was
slightly larger but acceptable (see Fig. 4b). All analysis
values for 11-OH-THC fall in the lower concentration
range where 11-OH-THC reveals the highest bias and
lowest repeatability of all compounds for both the auto-
mated (Table 3) and manual methods (not shown). This
may explain the larger deviations for 11-OH-THC in
comparison to THC and THC-COOH.
After successful validation, both the automated and
manual methods for the determination of THC and metab-
olites in serum are suitable for use in forensic toxicological
analysis. It is noteworthy that postmortem samples cannot
be analyzed ruggedly with the automated method because
of the possible formation of a gel during the extraction step
which cannot be separated by the standard centrifugation
method.
Conclusions
One manual and one fully automated analysis method
for THC, 11-OH-THC, and free, unconjugated THC-
COOH in blood serum were developed and successfully
validated according to GTFCh guidelines. Analysis
values were concordant, and both methods ensure that
only the free THC-COOH concentration is determined
and the analysis value is not erroneously increased by
THC-COOgluc coextraction and/or cleavage. Regarding
LOQs, extraction efficiencies, and precision, both devel-
oped methods correspond well to methods from the lit-
erature. The LOQ for THC of 1 μg/L required for driv-
ing under the influence of cannabis cases in Germany
can be reached, and the method can be employed in
that context.
To the best of our knowledge, this is the first publication on
a comprehensively automated classical liquid-liquid extrac-
tion workflow in the field of forensic toxicological analysis.
Also, the employed analysis system including shaker, centri-
fuge, and evaporator modules is mentioned for the first time in
the literature.
Table 5 Analysis results of a successfully passed round robin test (two
samples) and external control samples employing the comprehensively
automated method
Analyte Analysis value
[μg/L]
Target value
[μg/L]
Acceptable range
[μg/L]
THC 6.7a 6.0 3.9–8.1
3.9a 4.4 2.8–5.9
1.1b 1.1 0.6–1.6
8.5b 9.5 6.4–12
14b 20 14–26
11-OH-THC 3.1a 2.6 1.6–3.7
2.5a 2.6 1.5–3.6
1.1b 1.1 0.6–1.5
4.7b 5.0 3.2–6.8
9.8b 9.8 6.6–13
THC-COOH 75a 71 54–88
64a 63 47–78
8.4b 10 6.9–14
73b 71 54–88
141b 136 107–165
a Round robin test sample
b External control sample
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These are the main achievements and benefits:
& The automated method saves manual work and re-
duces the risk of human errors. This makes analysis
quality projectable and more independent of the hu-
man factor.
& By overlapping sample preparation and GC/MS run, the
comprehensively automated method has a throughput of
22 samples per day compared to 20 samples per day with
the manual workflow. Eighty-three minutes is needed for a
single analysis (including sample preparation, GC/MS
analysis, and the required blank analysis), meaning that
results are available 83 min after putting a single sample
onto the autosampler.
& The automated method can be employed for all types of
sera except postmortem samples.
& The automated system proved to be rugged and is
employed in our daily routine in the institute.
& The analysis system can be used for other matrices (e.g.,
saliva or urine) and other liquid-liquid extraction
workflows also outside the field of forensic toxicology
and is therefore of general interest.
& Other liquid-liquid extraction workflows in our laboratory
are actually under consideration for automation.
y = 1.06x + 0.15
R² = 0.9911
0
5
10
15
20
25
30
0 5 10 15 20 25
A
ut
om
at
ed
 M
et
ho
d 
[µ
g/
L]
Manual Method [µg/L]
Manual Method [µg/L]
THC
y = 1.42x -0.05
R² = 0.9068
0
2
4
6
8
10
12
14
16
0 2 4 6 8 10
A
ut
om
at
ed
 M
et
ho
d 
[µ
g/
L]
Manual Method [µg/L]
11-OH-THC
y = 1.04x + 4.57
R² = 0.9831
0
50
100
150
200
250
0 50 100 150 200 250
A
ut
om
at
ed
 M
et
ho
d 
[µ
g/
L]
THC-COOH
a
b
c
Fig. 4 Comparison of analysis
results for manual and automated
sample preparation of 20 real
samples: a THC, b 11-OH-THC,
c THC-COOH. Equations
resulting from linear regression
and coefficients of determination
are shown. Not all samples
included the analytes in
concentrations above the
respective limit of quantification
4386 K. Purschke et al.
Acknowledgments The authors thank their colleagues from the
Institute of Legal Medicine Essen, Germany, Department of Forensic
Toxicology, for sharing information on their method for THC analysis
in blood serum.
Compliance with ethical standards Coauthor Oliver Lerch is an em-
ployee of GERSTEL GmbH & Co. KG. GERSTEL instrumentation was
used in this research project. The other authors declare no conflicts of
interest.
Voluntary donors of blank blood samples from the Institute of Legal
Medicine in Giessen gave their informed consent to use their blood in this
study.
The study has been approved by the appropriate ethics committee and
has been performed in accordance with the ethical standards.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Schubert W, Dittmann V, Brenner-Hartmann J. Urteilsbildung in
der Fahrerlaubnisbegutachtung, Beurteilungskriterien. 3rd ed.
Bonn: Kirschbaum; 2013. p. 245–57.
2. Grotenhermen F. Pharmacokinetics and pharmacodynamics of can-
nabinoids. Clin Pharmacokinet. 2003;42:327–60.
3. Skopp G, Pötsch L. Zur präanalytischen Phase chemisch-
toxikologischer Untersuchungen II: Stabilität forensisch relevanter
Substanzen in Blut-, Plasma- oder Serumproben - eine
Bestandsaufnahme. Rechtsmedizin. 2002;12:195–202.
4. Daldrup T, Käferstein H, Köhler H, Maier RD, Musshoff F.
Entscheidung zwischen einmaligem/gelegentlichem und
regelmäßigem Cannabiskonsum. Blutalkohol. 2000;37:39–47.
5. Musshoff F, Madea B. Review of biologic matrices (urine, blood,
hair) as indicators of recent or ongoing cannabis use. Ther Drug
Monit. 2006;28:155–63.
6. Chi Chu MH, Drummer OH. Determination of Δ9-THC in whole
blood using gas chromatography-mass spectrometry. J Anal
Toxicol. 2002;26:575–81.
7. Moeller MR, Doerr G,Warth S. Simultaneous quantitation of delta-
9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta-9-tetra-
hydrocannabinol (THC-COOH) in serum by GC/MS using deuter-
ated internal standards and its application to a smoking study and
forensic cases. J Forensic Sci. 1992;37:969–83.
8. Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR.
Improved and validated method for the determination of Δ9-tetra-
hydrocannabinol, 11-hydroxy-THC and 11-nor-9-carboxy-THC in
serum, and in human liver microsomal preparations using gas
chromatography-mass spectrometry. J Chromatogr B. 2002;772:
239–48.
9. Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P,
Schefter T, et al. Simultaneous and sensitive analysis of THC, 11-
OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma
after oral application of small doses of THC and cannabis extract.
J Anal Toxicol. 2005;29:782–9.
10. Röhrich J, Schimmel I, Zörntlein S, Becker J, Drobnik S,
Kaufmann T, et al. Concentrations of Δ9-tetrahydrocannabinol
and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after
passive exposure to cannabis smoke in a coffee shop. J Anal
Toxicol. 2010;34:196–203.
11. Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA.
Validated method for the simultaneous determination of Δ9-tetra-
hydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-
THC in human plasma using solid phase extraction and gas
chromatography-mass spectrometry with positive chemical ioniza-
tion. J Chromatogr B. 2003;798:145–54.
12. Weller JP, Wolf M, Szidat S. Enhanced selectivity in the determi-
nation of Δ9-tetrahydrocannabinol and two major metabolites in
serum using ion-trap GC-MS-MS. J Anal Toxicol. 2000;24:359–
64.
13. Thomas A, Widmer C, Hopfgartner G, Staub C. Fast gas chroma-
tography and negative-ion chemical ionization tandem mass spec-
trometry for forensic analysis of cannabinoids in whole blood. J
Pharm Biomed. 2007;45:495–503.
14. Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA.
Simultaneous quantification of Δ9-tetrahydrocannabinol, 11-hy-
droxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9-tetrahydrocannab-
inol-9-carboxylic acid in human plasma using two-dimensional gas
chromatography, cryofocusing, and electron impact-mass spec-
trometry. J Chromatogr A. 2007;1163:318–27.
15. Scurlock RD, Ohlson GB, Worthen DK. The detection ofΔ9-tetra-
hydrocannabinol (THC) and 11-nor-9-carboxy- Δ9-tetrahydrocan-
nabinol (THCA) in whole blood using two-dimensional gas chro-
matography and EI-mass spectrometry. J Anal Toxicol. 2006;30:
262–6.
16. Maralikova B, Weinmann W. Simultaneous determination of Δ9-
tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and
11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma by
high-performance liquid chromatography/tandem mass spectrome-
try. J Mass Spectrom. 2004;39:526–31.
17. Laloup M, del Mar Ramirez Fernandez M, Wood M, De Boeck G,
Maes V, Samyn N. Correlation ofΔ9-tetrahydrocannabinol concen-
trations determined by LC-MS-MS in oral fluid and plasma from
impaired drivers and evaluation of the on-site Dräger DrugTest®.
Forensic Sci Int. 2006;161:175–9.
18. Del Mar Ramirez Fernandez M, De Boeck G, Wood M, Lopez-
Rivadulla M, Samyn N. Simultaneous analysis of THC and its
metabolites in blood using liquid chromatography-tandem mass
spectrometry. J Chromatogr B. 2008;875:465–70.
19. Jagerdeo E, Schaff JE, Montgomery MA, LeBeau MA. A semi-
automated solid-phase extraction liquid chromatography/tandem
mass spectrometry method for the analysis of tetrahydrocannabinol
and metabolites in whole blood. Rapid Commun Mass Spectrom.
2009;23:2697–705.
20. König S, Aebi B, Lanz S, Gasser M, Weinmann W. On-line SPE
LC-MS/MS for the quantification of Δ9-tetrahydrocannabinol
(THC) and its two major metabolites in human peripheral blood
by liquid chromatography tandem mass spectrometry. Anal
Bioanal Chem. 2011;400:9–16.
21. Schwope DM, Scheidweiler KB, HuestisMA. Direct quantification
of cannabinoids and cannabinoid glucuronides in whole blood by
liquid chromatography tandem mass spectrometry. Anal Bioanal
Chem. 2011;401:1273–83.
22. Dubois N, Paccou AP, DeBacker BG, Charlier CJ. Validation of the
quantitative determination of tetrahydrocannabinol and its two ma-
jor metabolites in plasma by ultra-high-performance liquid
chromatography-tandem mass spectrometry according to the total
error approach. J Anal Toxicol. 2012;36:25–9.
23. Toennes SW, Hanisch S, Pogoda W,Wunder C, Paulke A. Pitfall in
cannabinoid analysis—detection of a previously unrecognized in-
terfering compound in human serum. Anal Bioanal Chem.
2015;407:463–70.
24. Mauden M, Skopp G, Mattern R, Aderjan R. GC/MS-
determination of THCCOOH in serum: comparison of different
Automated determination of THC, 11-OH-THC, and free THC-COOH 4387
processing methods and the influence of THCCOOHglucuronide.
Blutalkohol. 2000;37:48–56.
25. Del Mar Ramirez Fernandez M, Wille SMR, Samyn N, Wood M,
Lopez-Rivadulla M, De Boeck G. High-throughput analysis of am-
phetamines in blood and urine with online solid-phase extraction-
liquid chromatography-tandem mass spectrometry. J Anal Toxicol.
2009;33:578–87.
26. Lerch O, Temme O, Daldrup T. Comprehensive automation of the
solid phase extraction gas chromatographic mass spectrometric
analysis (SPE-GC/MS) of opioids, cocaine, and metabolites from
serum and other matrices. Anal Bioanal Chem. 2014;406:4443–51.
27. He Y, Kang YJ. Single drop liquid-liquid-liquid microextraction of
methamphetamine and amphetamine in urine. J Chromatogr A.
2006;1133:35–40.
28. Dotsikas Y, Kousoulos C, Tsatsou G, Loukas YL. Development of
a rapid method for the determination of glimepiride in human plas-
ma using liquid-liquid extraction based on 96-well format micro-
tubes and liquid chromatography/tandemmass spectrometry. Rapid
Commun Mass Spectrom. 2005;19:2055–61.
29. Chemicalize.org. In: Properties Viewer, Search for: Bd-glucuronic
acid^ and B11-nor-9-carboxy-THC^. 2016. http://www.
chemicalize.org. Accessed 11 Jan 2016.
30. Peters FT, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff
F. Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei
forensisch-toxikologischen Untersuchungen - Anforderungen an
die Validierung von Analysenmethoden. Toxichem Krimtech.
2009;76:185–208.
4388 K. Purschke et al.
